Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
about
Development of new preclinical models to advance adrenocortical carcinoma research.Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.Emerging molecular mechanisms in chemotherapy: Ca2+ signaling at the mitochondria-associated endoplasmic reticulum membranes.Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis.Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
P2860
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Long-Term Outcomes of Adjuvant ...... cted Adrenocortical Carcinoma.
@en
type
label
Long-Term Outcomes of Adjuvant ...... cted Adrenocortical Carcinoma.
@en
prefLabel
Long-Term Outcomes of Adjuvant ...... cted Adrenocortical Carcinoma.
@en
P2093
P50
P356
P1476
Long-Term Outcomes of Adjuvant ...... ected Adrenocortical Carcinoma
@en
P2093
Alfredo Berruti
Alina Pulzer
Barbara Zaggia
Emanuela Arvat
Francesco Porpiglia
Fulvia Daffara
Guido Tiberio
Marco Boscaro
Massimo Mannelli
Massimo Terzolo
P304
P356
10.1210/JC.2016-2894
P407
P577
2017-04-01T00:00:00Z